Apollo Hospitals shares jump over 8% to hit all-time high on healthy growth in Q1 FY26 numbers

The country's largest private hospital chain operator on Tuesday reported a net profit of ₹433 crore in the first quarter of the current financial year (Q1FY26), marking an upside of 42% from ₹305 crore in the same period last year.

The Hyderabad-based company's revenue from operations in the April-June period rose 15% annually to ₹5,842 crore from ₹5,086 crore in the year-ago period.

Apollo Hospitals posted stable operational performance as its operating profit, also known as EBITDA (earnings before interest, taxes, depreciation and amortisation), rose 26% to ₹852 crore from ₹675 crore in the corresponding period last year. The company's EBITDA margin expanded by 130 basis points to 14.58% from 13.27%.

At close, shares of Apollo Hospitals settled at ₹7,830 apiece, soaring 8.2% on the National Stock Exchange. It was the biggest contributing stock on the 50-share index. The stock touched also touched its 52-week high on Wednesday.

The firm earned ₹2,974 crore in revenue from healthcare services, ₹435 crore from retail health and diagnostics business, and revenue from digital health and pharmacy distribution came in at ₹2,472 crore.

Profit from healthcare services came in at ₹562 crore, and profit from the digital health and pharmacy distribution business came in at ₹69 crore.

The company announced that it has acquired a 50% stake in Apollo Gleneagles PET-CT Private Limited (AGPCL) from Parkway Healthcare (Mauritius) PTE Limited for ₹8.5 crore.

The objective of the acquisition is to consolidate ownership and have full control over AGPCL's operations, enabling better integration with the company's diagnostic services and improving operational efficiencies, Apollo Hospitals said in a regulatory filing.

On the digital front, Apollo 24/7 achieved a quarterly GMV of over ₹682 crore, sustaining the platform's momentum and signalling the continuing strong demand for teleconsultations, lab and pharmacy deliveries.

The demerger of the digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and the omnichannel healthcare ecosystem, Apollo Hospitals said.

“Patient numbers across our network increased year-on-year, reflecting both the deeper penetration of our Centres of Excellence and the growing confidence of communities in our integrated care model. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over ~7,600 crore,” said Dr Prathap C Reddy, Chairman, Apollo Hospitals Enterprise.

“The first phase of 2,000 beds is already in progress. We have added an existing 200-bed hospital in Bengaluru and will also be establishing a 500-bed greenfield hospital in the suburbs of the city to bring the total bed strength in Bengaluru to 1,500 beds,” Reddy further added.

Reddy also said the company anticipates continued double-digit revenue growth for FY26, underpinned by new hospital openings in Patna and Jaipur slated for Q3. Further digital innovation and deepening partnerships with state governments to bolster community-based health initiatives, he said.

Over the last five trading days, Apollo Hospitals shares soared over 7%, while for a month’s period, the stock gained 6.5%. Since February 13, 2025, which is six months, shares of the firm have climbed 21%.

The company’s market capitalisation stands at ₹1.11 lakh crore.